Quick Answer
PULSE BIOSCIENCES, INC. reported Total Revenue of $350.0 thousand for fiscal year 2025.
PULSE BIOSCIENCES, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $350.0K | $0.00 | $0.00 -100.0% |
$700.0K -50.6% |
$1.42M | $0.00 |
| Revenue (ASC 606) | $350.0K | $0.00 | $0.00 -100.0% |
$700.0K -50.6% |
$1.42M | $0.00 |
| Net Income | -$72.78M -35.8% |
-$53.59M -26.9% |
-$42.21M +27.9% |
-$58.51M +8.1% |
-$63.66M -27.7% |
-$49.85M -6.1% |
| Total Assets | $94.54M -28.6% |
$132.46M +123.9% |
$59.15M -24.0% |
$77.88M +43.6% |
$54.25M +31.4% |
$41.29M -1.5% |
| Cash and Equivalents | $80.73M -31.6% |
$118.04M +166.1% |
$44.37M -27.4% |
$61.14M +113.7% |
$28.61M +129.6% |
$12.46M +80.6% |
| Stockholders Equity | $80.66M -29.8% |
$114.86M +158.9% |
$44.36M +2073.3% |
-$2.25M -106.3% |
$35.69M +55.9% |
$22.89M -25.5% |
| R&D Expense | $44.72M +38.3% |
$32.34M +16.3% |
$27.80M +33.4% |
$20.84M -27.2% |
$28.64M +8.3% |
$26.44M +5.9% |
| Operating Income | -$76.94M -36.8% |
-$56.26M -29.1% |
-$43.57M +24.9% |
-$58.06M +7.9% |
-$63.01M -26.1% |
-$49.97M -4.2% |
| Shares Outstanding | 67.84M +2.9% |
65.93M +19.6% |
55.14M +48.1% |
37.23M +25.3% |
29.72M +16.3% |
25.55M +22.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $86.0K | — | — |
| Revenue (ASC 606) | September 30, 2025 | $86.0K | — | — |
| Net Income | September 30, 2025 | -$19.39M | -52.9% | -1.1% |
| Diluted EPS | September 30, 2022 | -$0.49 | -2.1% | -11.4% |
| Total Assets | September 30, 2025 | $108.77M | +16.9% | -9.6% |
| Cash and Equivalents | September 30, 2025 | $95.21M | +20.5% | -10.5% |
| Stockholders Equity | September 30, 2025 | $92.69M | +17.1% | -11.3% |
| R&D Expense | September 30, 2025 | $11.39M | +47.9% | -5.7% |
| Operating Income | September 30, 2025 | -$20.37M | -49.2% | -0.5% |
| Shares Outstanding | September 30, 2025 | 67.74M | +10.1% | +0.7% |
- PULSE BIOSCIENCES, INC. reported Total Revenue of $350.0 thousand for fiscal year 2025.
- PULSE BIOSCIENCES, INC. reported Revenue (ASC 606) of $350.0 thousand for fiscal year 2025.
- PULSE BIOSCIENCES, INC. reported Net Income of -$72.78 million for fiscal year 2025.
- PULSE BIOSCIENCES, INC. showed a decrease of -35.8% in Net Income compared to the prior fiscal year.
- PULSE BIOSCIENCES, INC. reported Total Assets of $94.54 million for fiscal year 2025.
- PULSE BIOSCIENCES, INC. showed a decrease of -28.6% in Total Assets compared to the prior fiscal year.
- PULSE BIOSCIENCES, INC. reported Cash and Equivalents of $80.73 million for fiscal year 2025.
- PULSE BIOSCIENCES, INC. showed a decrease of -31.6% in Cash and Equivalents compared to the prior fiscal year.
- PULSE BIOSCIENCES, INC. reported Stockholders Equity of $80.66 million for fiscal year 2025.
- PULSE BIOSCIENCES, INC. showed a decrease of -29.8% in Stockholders Equity compared to the prior fiscal year.
- PULSE BIOSCIENCES, INC. reported R&D Expense of $44.72 million for fiscal year 2025.
- PULSE BIOSCIENCES, INC. showed an increase of +38.3% in R&D Expense compared to the prior fiscal year.
- PULSE BIOSCIENCES, INC. reported Operating Income of -$76.94 million for fiscal year 2025.
- PULSE BIOSCIENCES, INC. showed a decrease of -36.8% in Operating Income compared to the prior fiscal year.
- PULSE BIOSCIENCES, INC. reported Shares Outstanding of 67.84 million shares for fiscal year 2025.
- PULSE BIOSCIENCES, INC. showed an increase of +2.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: